This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrinology
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:32551/feed
ISSN 2327-2236
Urological/Gynecological Diseases
Vol. 5, Issue 2, 2018January 09, 2018 EDT

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

Carlos Crespo, Pedro Blasco, Marcelo Guigini, Jordi Galván,
oral muscarinic antagonistsmirabegronpersistencecost–effectivenessoxybutynin transdermal patchidiopathic overactive bladder
Copyright Logoccby-4.0 • https://doi.org/10.36469/9811

Articles in Vol. 5, Issue 2, 2018

Vol. 5, Issue 2, 2018
  • Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
    Sue PereraLiyuan MaRaj PunwaneySulabha Ramachandran
  • Real-world Bleeding Outcomes and Costs Following Vascular Graft Anastomosis Using PROLENE Sutures with HEMO-SEAL Technology in Patients Undergoing Abdominal Aortic Aneurysm Repair
    Nadia Y. SuttonNiels-Derrek Schmitz
  • Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
    Carlos CrespoPedro BlascoMarcelo GuiginiJordi Galván
  • Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain
    María Teresa Gómez-CasaresJuan Carlos Hernández-BoludaAntonio Jiménez-VelascoJoaquin Martínez-LópezMaría Giovanna FerrarioIrmina GozalboJoana GostkorzewiczRudi Subirá
  • The 500-year Cultural & Economic Trajectory of Tobacco: A Circle Complete
    Christopher A. JonesAmanda WasselWilliam MierseE. Scott Sills
  • Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy
    George RuizJason YeawCassandra A. LickertAjita P. DeRolin L. WadeJanis PruettWilliam Drake
  • The Association of COPD Exacerbations with New Onset Type 2 Diabetes among Medicare Patients
    Joseph S. MarinoCynthiya RubanChristopher M. Blanchette
  • A Cost-benefit Analysis of Using Polyethylene Glycol Hydrogel Sealant versus Fibrin Glue as a Dural Sealant for Posterior Fossa Surgery in the United States
    Marissa J. Carter
JHEOR
1.
Crespo C, Blasco P, Guigini M, Galván J. Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain. JHEOR. 2018;5(2):194-205. doi:10.36469/9811
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system